---
title: "Casil Health Products Ltd(merged) (523254) — Share Price, Financials & Analysis"
symbol: "523254"
company: "Casil Health Products Ltd(merged)"
canonical: "https://tapetide.com/stocks/523254"
isin: "INE288F01012"
bse_code: "523254"
generated_at: "2026-10-13T11:00:00.783Z"
---

# Casil Health Products Ltd(merged) (523254)

Canonical page: https://tapetide.com/stocks/523254

## Company

- **BSE Code:** 523254
- **ISIN:** INE288F01012
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** casilhealth.com

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Company has high debtors of 175 days.

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 369 | 348 | 231 | 220 | 253 | 488 | 604 | 676 | 840 | 549 | 556 | 545 |
| Expenses | 198 | 181 | 133 | 154 | 180 | 363 | 398 | 439 | 611 | 437 | 435 | 449 |
| Operating Profit | 172 | 167 | 98 | 66 | 73 | 125 | 205 | 237 | 229 | 112 | 121 | 95 |
| OPM % | 47 | 48 | 42 | 30 | 29 | 26 | 34 | 35 | 27 | 20 | 22 | 18 |
| Other Income | 11 | 11 | 20 | 14 | 17 | 19 | 16 | 22 | -4 | 6 | 16 | 1 |
| Interest | 5 | 1 | 0 | 2 | 2 | 10 | 10 | 11 | 10 | 10 | 9 | 9 |
| Depreciation | 12 | 13 | 12 | 13 | 17 | 31 | 38 | 44 | 54 | 45 | 44 | 47 |
| Profit before tax | 166 | 164 | 105 | 65 | 71 | 103 | 174 | 205 | 161 | 63 | 84 | 41 |
| Tax % | 25 | 26 | 25 | 29 | 25 | 27 | 21 | 25 | 27 | 26 | 21 | 29 |
| Net Profit | 124 | 121 | 80 | 47 | 53 | 75 | 138 | 153 | 117 | 46 | 66 | 29 |
| EPS in Rs | 4.87 | 4.74 | 3.13 | 1.84 | 2.1 | 2.96 | 5.44 | 6.01 | 4.73 | 1.28 | 1.94 | 0.96 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 |
| --- | --- |
| Sales | 13.28 |
| Expenses | 12.76 |
| Operating Profit | 0.52 |
| OPM % | 3.92 |
| Other Income | 0.15 |
| Interest | 0.57 |
| Depreciation | 0.02 |
| Profit before tax | 0.08 |
| Tax % | 50 |
| Net Profit | 0.04 |
| Dividend Payout % | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 |
| --- | --- |
| Equity Capital | 0.05 |
| Reserves | -0.2 |
| Borrowings | 5.04 |
| Other Liabilities | 4.72 |
| Total Liabilities | 9.61 |
| Fixed Assets | 0.11 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets | 9.5 |
| Total Assets | 9.61 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 50 | 407 | 383 | 330 | 457 | 358 | 288 |
| Cash from Investing Activity | -65 | -413 | -311 | -136 | -195 | -362 | -253 |
| Cash from Financing Activity | 26 | 7 | -76 | -156 | -242 | -14 | 3 |
| Net Cash Flow | 11 | 1 | -5 | 37 | 20 | -18 | 38 |

### Ratios

| Item | Mar 2006 |
| --- | --- |
| Debtor Days | 175.08 |
| Inventory Days | 99.65 |
| Days Payable | 181.51 |
| Cash Conversion Cycle | 93.22 |
| Working Capital Days | 123.13 |

## Shareholding Pattern

### annual

| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60% | 60% | 60% | 60% | 50.1% | 50.1% | 57.49% |
| FIIs | 0% | 6.93% | 8.56% | 9.47% | 9.54% | 11.05% | 6.01% |
| DIIs | 8.19% | 5.52% | 6.56% | 11.43% | 17.24% | 16.6% | 21.57% |
| Government | 0% | 0% | 0% | 0% | 0.01% | 0.01% | 0.01% |
| Public | 31.81% | 27.55% | 24.88% | 19.1% | 23.11% | 22.24% | 14.91% |
| No. of Shareholders | 60684 | 75207 | 85725 | 72885 | 68932 | 86325 | 81877 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60% | 60% | 60% | 60% | 50.1% | 50.1% | 50.1% | 50.1% | 50.1% | 66.41% | 57.49% | 57.49% |
| FIIs | 9.47% | 9.5% | 10.01% | 10.14% | 9.54% | 9.8% | 10.7% | 10.84% | 11.05% | 7.23% | 6.51% | 6.01% |
| DIIs | 11.43% | 10.63% | 14.13% | 15.94% | 17.24% | 17.42% | 16.95% | 16.67% | 16.6% | 11.4% | 20.81% | 21.57% |
| Government | 0% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 19.1% | 19.88% | 15.85% | 13.93% | 23.11% | 22.67% | 22.26% | 22.37% | 22.24% | 14.95% | 15.16% | 14.91% |
| No. of Shareholders | 72885 | 72167 | 73715 | 70052 | 68932 | 65777 | 69337 | 84210 | 86325 | 80910 | 75284 | 81877 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 236.68 | Sell |
| EMA (10) | 235.38 | Sell |
| SMA (20) | 244.45 | Sell |
| EMA (20) | 240.91 | Sell |
| SMA (50) | 249.74 | Sell |
| EMA (50) | 247.83 | Sell |
| SMA (100) | 255.67 | Sell |
| EMA (100) | 254.1 | Sell |
| SMA (200) | 263.38 | Sell |
| EMA (200) | 266.2 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.12 | Neutral |
| MACD (12,26,9) | -6.04 | Sell |
| Stochastic (14,3,3) | 9.93 | Buy |
| ADX (14) | 16.76 | Neutral |
| Williams %R (14) | -85.31 | Buy |
| ATR (14) | 11.68 | High Volatility |
| ROC (12) | -9.78 | Sell |
| Stoch RSI (14) | 12.14 | Buy |
| UO (7,14,28) | 39.06 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/35429898-93ea-4da9-a7cd-91fc87c82c0d.pdf) |
| 2026-02-24 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9B2C7929_9579_4DD8_BFDB_DE4FC59B051A_170015.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70fe8774-245a-4523-99d9-bbbcaa12bb70.pdf) |
| 2026-02-20 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011](https://www.bseindia.com/xml-data/corpfiling/AttachHis/D976A874_1AC7_4D16_997A_2EBC1CC45911_165656.pdf) |
| 2026-02-20 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011](https://www.bseindia.com/xml-data/corpfiling/AttachHis/C3CAE29D_3757_41D5_96B0_F1D55E1C277C_165851.pdf) |
| 2026-02-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c638b906-1424-494c-9c75-ec69a5e7a8cd.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7b4eb59-cbe9-4db4-aebb-a24ded61d618.pdf) |
| 2026-02-12 | [Outcome Of Board Meeting](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0397614a-7158-46d8-b89a-ba9953de9bbe.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachLive/58387b0d-b3f2-43fd-9542-6c89585316cd.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c729453b-92f9-4ad2-945a-63838e479a7f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95288350-4921-470f-b5c3-0b540b626a1b.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fec80c4b-d2f3-496a-9e3b-d263ba26c9f7.pdf) |
| 2023 | [Financial Year 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8a5776c-da4c-473b-b815-a99242494f9a.pdf) |
| 2022 | [Financial Year 2022](https://www.bseindia.com/bseplus/AnnualReport/543064/73898543064.pdf) |
| 2021 | [Financial Year 2021](https://www.bseindia.com/bseplus/AnnualReport/543064/69343543064.pdf) |
| 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/543064/64909543064_17_09_20.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c638b906-1424-494c-9c75-ec69a5e7a8cd.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af10d29e-7173-4207-9ccf-86a033601f6e.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e151379c-afe1-4ba5-a005-6f08a84d0cf4.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5bb5a8f-229c-40b8-b3cb-c40f09a91bdb.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12e3bc92-c179-4924-b331-cd06f046178a.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/654a8886-30e6-4ce7-be5d-dba4ae41cad4.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b8256e9-3113-47df-be4b-acefc441005e.pdf) |
| Dec 2024 | [Concall - Dec 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2bd328a-a01c-4ee6-a211-eeed80578b93.pdf) |
| Dec 2024 | [Concall - Dec 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/281de5ca-dafb-47bd-ae52-241b68ccc7fa.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2fa99890-a8ba-40ca-a67e-43efc369781a.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-12-03 | Credit rating update — India Ratings |
| 2025-08-26 | Credit rating update — CRISIL |
| 2025-07-23 | Credit rating update — CARE Ratings |
| 2025-05-28 | Credit rating update — CRISIL |
| 2025-02-27 | Credit rating update — CRISIL |
| 2024-11-29 | Credit rating update — CRISIL |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:00:00.783Z.